HR Business Partner (all genders) (Vollzeit, unbefristet) at Abbvie

Abbvie

Ludwigshafen, RP, de·3d ago

Entry LevelFull-time

Salary Range

$17,850 - $24,150 /year

Estimated

This salary is estimated based on similar roles. The actual salary may vary.

About the Role

We are looking for a strategic HR Business Partner to support leadership in the R&D department. This role focuses on talent management, organizational development, and ensuring the future readiness of the organization.

Key Responsibilities

→Serve as a strategic HR Business Partner for R&D leadership
→Advise leadership on talent management, retention, development, change management, and organizational development
→Support departments with leadership and employee development using assessment tools like 360° Feedback
→Proactively manage talent and performance using key metrics
→Collaborate with Talent Acquisition for key position filling and talent pipeline development
→Manage restructuring projects and support leadership during organizational changes
→Conduct annual talent review processes and ensure action planning for talent and succession planning
→Manage annual goal setting, performance evaluation, and salary review processes
→Participate in local and global HR projects
→Work closely with HR functions like Total Rewards, Talent Management, and Talent Acquisition
→Maintain cooperation with the works council

Requirements

✓Proven experience as an HR Business Partner, preferably in R&D or technology sectors
✓Strong understanding of talent management, performance management, and organizational development
✓Experience with assessment tools and talent acquisition strategies
✓Ability to manage complex HR projects and organizational changes
✓Excellent communication and interpersonal skills
✓Knowledge of labor laws and works council regulations
✓Strategic thinking and problem-solving abilities

Free to sign up. Takes 30 seconds.

Share this job

LinkedIn Twitter Telegram

About Abbvie

Abbvie is a global biopharmaceutical company specializing in the research, development, and commercialization of innovative therapies. Headquartered in North Chicago, Illinois, the company was founded in 2013 following the spin-off of Abbott Laboratories' pharmaceutical division. Abbvie operates at the forefront of the biotechnology and pharmaceutical industries, focusing on addressing complex diseases and improving patient outcomes through scientific advancement. The company's primary products include treatments for immunology, oncology, and neurology, with its flagship drug, Humira, being one of the best-selling medications globally. Abbvie is known for its robust pipeline of investigational therapies, leveraging cutting-edge research and clinical trials to bring novel treatments to market. Its target audience includes patients, healthcare providers, and payers, with a particular emphasis on those suffering from chronic and life-threatening conditions. Key features of Abbvie's offerings include targeted therapies, personalized medicine approaches, and a commitment to regulatory compliance and safety. Abbvie has achieved significant milestones, including maintaining a leading position in the global pharmaceutical market and generating substantial revenue through its innovative portfolio. The company's unique value proposition lies in its dedication to scientific excellence and patient-centric care, supported by a strong pipeline and strategic investments in research and development. Abbvie's market position is further strengthened by its global reach, collaborative partnerships, and a reputation for delivering transformative therapies.